Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

313.25 +4.78 (+1.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
Get in on CRISPR Therapeutics before it gets expensive. 
Via The Motley Fool
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell Therapy for the Treatment of Type 1 Diabetes
From Vertex Pharmaceuticals Incorporated
Via Business Wire
4 Growth Stocks to Buy and Hold Forever
These stocks have what it takes to achieve long-term success. 
Via The Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
These companies have what it takes to survive and thrive beyond the next bear market. 
Via The Motley Fool
7 Cathie Wood Stocks for Your March Buy List
These top Cathie Wood stocks are just now attempting to pivot higher after a miserable outing for much of 2022. 
Via InvestorPlace
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest
 
Via Benzinga
3 Stocks to Buy Right Now That Are Cash Cows
If cash is king, these three stocks should wear crowns. 
Via The Motley Fool
2 No-Brainer Growth Stocks to Buy Right Now
Don't let these incredible businesses pass you by. 
Via The Motley Fool
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
CRISPR Therapeutics, Beam Therapeutics and Vertex Pharmaceuticals are three CRISPR gene editing stocks you won't want to miss out on. 
Via InvestorPlace
3 Things About CRISPR Therapeutics That Smart Investors Know
Institutional investors might be on to something. 
Via The Motley Fool
3 Game-Changing Stocks to Buy in March
Innovation is in these companies' DNA. 
Via The Motley Fool
Prediction: These 3 S&P 500 Stocks Will at Least Double in 7 Years
These large-cap stocks should grow much larger. 
Via The Motley Fool
2 Growth Stocks to Invest $1,000 in Right Now
Both of these biopharmas have major catalysts that are in play or drawing near. 
Via The Motley Fool
3 Nasdaq 100 Stocks to Buy Hand Over Fist in March
The predominantly growth-oriented Nasdaq 100 is home to three amazing deals hiding in plain sight. 
Via The Motley Fool
3 Incredible Growth Stocks to Buy if the Market Dips
These top growth stocks sport premium valuations for a very good reason. 
Via The Motley Fool
ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing
 
Via Benzinga
Here's How Much You Can Make From Investing Your Tax Return Every Year
Doing this can strengthen your retirement plan. 
Via The Motley Fool
3 Top Stocks to Invest $3,000 in Right Now
These three stocks have tremendous growth prospects. 
Via The Motley Fool
Nasdaq Bear Market: 5 Superb Growth Stocks You'll Regret Not Buying on the Dip
A 33% plunge in the Nasdaq Composite is the perfect excuse for opportunistic investors to pounce on innovation-driven businesses. 
Via The Motley Fool
Better Buy: Beam Therapeutics or Intellia Therapeutics?
The two clinical-stage gene-editing companies have good long-term prospects. 
Via The Motley Fool
Vertex to Present at Cowen’s 43rd Annual Health Care Conference on March 7
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These stocks have something to offer every type of investor. 
Via The Motley Fool
Got $1,500? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
These companies are raking in profits and growing at a speed that outpaces the competition. 
Via The Motley Fool
A Recession Could Be More Likely Now: Here's What Investors Should Do
There's one strategy that's the best approach of all. 
Via The Motley Fool
3 Top Stocks to Buy and Hold for the Next Decade and Beyond
The sky is the limit for these stocks. 
Via The Motley Fool
Chances of a New Bull Market Fading? 2 Great Stocks to Buy Anyway
These two stocks are unstoppable leaders. 
Via The Motley Fool
2 Monster Stocks to Buy Hand Over Fist in 2023
A pandemic favorite and a healthcare growth stock each have something to add to the long-term investor's portfolio. 
Via The Motley Fool
Robinhood, Merck And 2 Other Stocks Insiders Are Selling
The Nasdaq closed higher by around 0.6% on Tuesday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Prime Healthcare Takeover Targets
These three companies are attractive targets for their potential. 
Via The Motley Fool
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.